Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 5/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.32 |
| ▸ | SQLE | Q14534 | 1/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2445516 | 1.00 | ALOX15 (0.42) | ALOX15ALDH1A1TSHRSRCSQLE | |
| SCHEMBL3901659 | 0.81 | ALOX15 (0.40) | ALOX15ALDH1A1TSHRSRC | |
| SCHEMBL3909207 | 0.80 | ALOX15 (0.39) | ALOX15ALDH1A1TSHR | |
| SCHEMBL3901906 | 0.78 | ALOX15 (0.37) | ALOX15ALDH1A1TSHRUSP2 | |
| SCHEMBL3904245 | 0.78 | ALOX15 (0.37) | ALOX15ALDH1A1TSHR | |
| SCHEMBL3897147 | 0.78 | ALOX15 (0.37) | ALOX15ALDH1A1TSHR | |
| SCHEMBL580621 | 0.77 | ALOX15 (0.31) | ALOX15ALDH1A1TSHR | |
| SCHEMBL17335748 | 0.75 | ALOX15 (0.48) | ALOX15ALDH1A1TSHRSRCUSP2 | |
| SCHEMBL3904740 | 0.74 | GLA (0.38) | ALOX15ALDH1A1TSHRTDP1 | |
| SCHEMBL22445206 | 0.73 | KMT2A (0.44) | ALOX15ALDH1A1SQLE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2160176-B1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2017-07-26 | — | — | EP | claimed |
| US-8431520-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2013-04-30 | — | — | US | disclosed |
| US-20130012422-A1 | PERFUME SYSTEMS | SMETS JOHAN (BE) | 2013-01-10 | — | — | US | disclosed |
| US-20100137178-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2010-06-03 | — | — | US | disclosed |
| EP-1762565-B1 | Alkyl substituted octennitrile derivatives | INT FLAVORS & FRAGRANCES INC (US) | 2009-03-18 | — | — | EP | disclosed |
| EP-1762565-B1 | Alkyl substituted octennitrile derivatives | INT FLAVORS & FRAGRANCES INC (US) | 2009-03-18 | — | — | EP | disclosed |
| US-7361630-B2 | Alkyl substituted octennitrile derivatives | INTERNATIONAL FLAVORS & FRAGRANIES INC. (US) | 2008-04-22 | — | — | US | disclosed |
| US-7361630-B2 | Alkyl substituted octennitrile derivatives | INTERNATIONAL FLAVORS & FRAGRANIES INC. (US) | 2008-04-22 | — | — | US | disclosed |
| US-7361630-B2 | Alkyl substituted octennitrile derivatives | INTERNATIONAL FLAVORS & FRAGRANIES INC. (US) | 2008-04-22 | — | — | US | disclosed |
| EP-1762565-A1 | Alkyl substituted octennitrile derivatives | INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) | 2007-03-14 | — | — | EP | disclosed |
| EP-1762565-A1 | Alkyl substituted octennitrile derivatives | INTERNATIONAL FLAVORS & FRAGRANCES, INC. (US) | 2007-03-14 | — | — | EP | disclosed |
| US-20070055082-A1 | Alkyl substituted octennitrile derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2007-03-08 | — | — | US | disclosed |
| US-20070055082-A1 | Alkyl substituted octennitrile derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2007-03-08 | — | — | US | disclosed |
| US-20070055082-A1 | Alkyl substituted octennitrile derivatives | INTERNATIONAL FLAVORS & FRAGRANCES INC. | 2007-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012422-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | ALOX15 544/4885ALDH1A1 1194/4885TSHR 4772/4885 |
| US-20070055082-A1 | Alkyl substituted octennitrile derivatives | ARNT, HCCS, AHR | ALOX15 1051/4885ALDH1A1 2282/4885TSHR 2221/4885 |
| US-20100137178-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | ALOX15 544/4885ALDH1A1 1194/4885TSHR 4772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.